Cullinan Therapeutics (CGEM) Tax Rate (2022 - 2023)
Cullinan Therapeutics (CGEM) posted quarterly Tax Rate of 35.53% for Q4 2023, down 4209.0% year-over-year from 0.86% in Q4 2022, and down 641.29% quarter-over-quarter from 6.56% in Q4 2022.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) Tax Rate (2022 - 2023) Analysis & Trends
Cullinan Therapeutics' Tax Rate history runs 2 years deep, the most recent figure standing at 35.53% for Q4 2023.
- In Q4 2023, Tax Rate fell 4209.0% year-over-year to 35.53%; the TTM figure through Dec 2023 stood at 8.33% (down 3614.0% YoY), while the FY2024 annual figure was 21.09%, up 2942.0% from the prior year.
- Tax Rate for Q4 2023 stood at 35.53%, down from 6.56% in the prior quarter.
- The five-year high for Tax Rate was 60.28% in Q1 2022, with the low at 35.53% in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -16.71% |
| 10 | Cullinan Therapeutics | 1.37 Bn | 1.37 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 35.59% |
| Dec 31, 2022 | 6.49% |
| Sep 30, 2022 | 9.20% |
| Jun 30, 2022 | 27.51% |
| Mar 31, 2022 | 60.38% |